Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Curious about Moderna (MRNA) Q2 Performance? Explore Wall Street Estimates for Key Metrics
10:16am, Tuesday, 29'th Jul 2025
Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?
09:31am, Tuesday, 29'th Jul 2025
MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline milestones.
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?
11:31am, Monday, 28'th Jul 2025
Let's look at five biotech and drug companies, MRK, AZN, BMY, ABBV and MRNA, slated to release their second-quarter 2025 results this week.
Moderna Announces Data to be Presented at ESMO Congress 2025
07:00am, Monday, 28'th Jul 2025
CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2
Down 74% Over the Past Year, Is Moderna Stock a Buy?
03:55am, Saturday, 26'th Jul 2025
In the short term, Moderna (MRNA 0.41%) looks like a bad bet. It's coming off of the momentum of its COVID-19 vaccine, and doesn't have a lot of new ammo ready yet to expand in new directions.
EU regulator backs Moderna's updated COVID vaccine
11:41am, Friday, 25'th Jul 2025
The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the vaccine maker said on Friday.
Moderna (MRNA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Friday, 25'th Jul 2025
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision CAMBRIDGE, MA / ACCESS Newswire / July 25, 2025 / M
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
06:51pm, Thursday, 24'th Jul 2025
In the latest trading session, Moderna (MRNA) closed at $34.01, marking a -1.9% move from the previous day.
What's Going On With Moderna Stock Wednesday?
03:14pm, Wednesday, 23'rd Jul 2025
Moderna Inc.'s MRNA stock has surged approximately 37% in the last month but has dipped around 15% year to date.
How IBM and Moderna's partnership could lead to an explosion in drug development
12:31am, Saturday, 19'th Jul 2025
The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments.
Here's Why Moderna (MRNA) Fell More Than Broader Market
06:51pm, Friday, 18'th Jul 2025
In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Friday, 18'th Jul 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Moderna cancels plans to build Japan plant on poor business environment
06:12am, Friday, 18'th Jul 2025
Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the business environment" around the world and in Japan.
Moderna: Ready For The Redemption Arc
08:00am, Tuesday, 15'th Jul 2025
Moderna's stock has faced heavy pressure from negative headlines, regulatory setbacks, and political uncertainty, but recent FDA approvals have stabilized sentiment. The company now boasts three appro
